Original release date: April 4, 2023
Access to this course expires on:  February 4, 2026 at 11:59 PM Pacific Time
CME 18

Course Description
Pathologists have historically dedicated their efforts to recognizing and classifying patterns of disease based on careful morphologic assessment, unassisted by immunohistochemical and molecular techniques. Many pathologists lack the fundamental skills to interpret patterns of injury or neoplasia that are required to generate a workable differential diagnosis. As a result, they often perform excessive ancillary studies that exhaust materials and contribute to escalating health care costs. Diagnoses may be delayed due to multiple rounds of testing, especially when unusual staining patterns or conflicting results are encountered.

Recent advances in immunohistochemical and molecular techniques have led to a paradigm shift such that we increasingly rely upon ancillary assays to facilitate or establish a diagnosis. This course is intended to emphasize the continued role of histomorphology in the classification of human diseases while highlighting the accomplishments of leaders in our field. All of the faculty members are current, or former presidents of the United States and Canadian Academy of Pathology and/or the Arthur Purdy Stout Society of Surgical Pathologists. These individuals have tremendous knowledge to share with learners at all stages in their careers.

Target Audience

Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives

Upon completion of this educational activity, learners will be able to:

• Apply a pattern-based approach to non-neoplastic lung diseases
• Develop a short differential diagnosis for mesenchymal tumors based on an assessment of morphologic features
• Recognize key diagnostic features in breast needle core biopsies
• Distinguish between syndromic polyps of the gastrointestinal tract

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of United States and Canadian Academy of Pathology (USCAP) and Arthur Purdy Stout Society of Surgical Pathologists (APSS). The USCAP is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 18 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Rhonda K. Yantiss, MD, Laura C. Collins, MD, Christopher D.M. Fletcher, MD, FRCPath, Wendy L. Frankel, MD, Jeffrey L. Myers, MD, Victor E. Reuter, MD

The following IM Coordinator who planned and reviewed content for this activity reported no relevant financial relationships: Andrew Folpe, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. Learners can now self-submit CME on all earned certificates. View and print your certificates by clicking here.

USCAP members receive a discount on all e-Learning courses. Not A Member? Click Here to sign up today.